Hoffman-LaRoche Inc. Roche Group

Hoffman-LaRoche Inc. (Roche), based in Nutley, N.J., is the U.S. prescription drug unit of the Roche Group, a leading research-based health care enterprise that ranks among the world’s leaders in pharmaceuticals, diagnostics and vitamins. Roche discovers, develops, manufactures and markets numerous important prescription drugs that enhance people’s health, well-being and quality of life. Among the company’s areas of therapeutic interest are: virology, including HIV/AIDS and hepatitis C; infectious diseases, including influenza; cardiology; neurology; oncology; transplantation; dermatology; and metabolic diseases, including obesity and diabetes.

Hoffman-LaRoche Inc. has remained at the forefront of biomedical knowledge through virtually every decade of its existence. The company’s achievements range from the first commercial synthesis of vitamins in the 1930s to the introduction of antimicrobials in the 1940s; from psychotherapeutics in the 1950s and 1960s to the birth of biotechnology in the 1980s; all the way to the latest breakthroughs in the diagnosis and treatment of AIDS, the management of obesity, and the prevention of organ rejection in the 1990s.

Roche’s reputation for medical advances is complemented by a commitment to corporate social responsibility, as demonstrated through initiatives in patient information, math, and science education, drug abuse prevention, environmental protection, and support of community and voluntary health organizations.

Today, Roche has approximately 66,000 employees worldwide and operates in more than 100 countries. While much has changed since the company’s inception, our mission has remained constant: to improve patient care discovering, developing, manufacturing and marketing innovative, high-quality and cost-effective healthcare products and services.

The Healthcare of Foundation of New Jersey

The mission of The Healthcare Foundation of New Jersey (formerly known as the NBI Healthcare Foundation) is to alleviate the suffering of the most vulnerable members of our community. Our goal is to identify and strengthen existing healthcare programs and to seed innovative projects that address unmet healthcare needs. Through the funding of strategic and transformational proposals, we hope to reach out and positively impact the underserved communities in our area.

In 1901, with the inauguration of the Newark Beth Israel Hospital, the Jewish community of Newark, New Jersey established a strong tradition of delivering the highest standards of medical care. The Healthcare Foundation of New Jersey, a private grantmaking institution founded in 1996, is firmly rooted in this great heritage. The Healthcare Foundation of New Jersey is particularly grateful to the generations of caring Jewish women and men who generously created and supported a lasting legacy of healthcare in Newark and Essex County. It is the hope of The Healthcare Foundation of New Jersey to follow in the footsteps of those philanthropic individuals who embodied the ideals of tzedakah (social justice) and tikkun olum (repairing the world).

The Board of Trustees of The Healthcare Foundation of New Jersey has identified four priority giving areas for grant support:

Programs that address the healthcare needs of the vulnerable children and families of Newark, especially Newark's South Ward

Programs that address the healthcare needs of the vulnerable individuals of the MetroWest Jewish community of Northern New Jersey

Proposals related to medical education and humanism in medicine

Clinical medical research, especially at the Newark Beth Israel Medical Center